Evidence map›Paper›PMID 34215920›Full record

ArticleEuropean journal of nutrition2022

Multi-omics integration reveals the hepatoprotective mechanisms of ursolic acid intake against chronic alcohol consumption.

Xin Yan, Xiaoyun Liu, Yu Wang, Xueyang Ren, Jiamu Ma, Ruolan Song, Xiuhuan Wang, Ying Dong, Qiqi Fan, Jing Wei and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Impact of NQO1 dysregulation in CNS disorders.Journal of translational medicine · 2024
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Xin YanSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Xiaoyun LiuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Yu WangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Xueyang RenSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Jiamu MaSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Ruolan SongSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Xiuhuan WangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Ying DongSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Qiqi FanSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Jing WeiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Axiang YuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Hong SuiSchool of Chinese Pharmacy, Ningxia Medical University, Yinchuan, 750004, China.
Gaimei SheSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China. shegaimei@126.com.
Beijing University of Chinese Medicine · CNNingxia Medical University · CN

Funding

Fundamental Research Funds for Central Universities of the Central South University 2018-JYBZZ-JS017National Natural Science Foundation of China 81760769
6 · The paper itself

Abstract

purposeAlcoholic liver disease (ALD) is a major health issue globally. In addition to pharmacotherapy, dietary support is also regarded as reliable strategy for ALD management. As a widely distributed natural constituent within edible plants, the present study aims to investigate the hepatoprotective effects of ursolic acid (UA) against ALD and also to deepen insights into the underlying targets and mechanisms comprehensively.

methodsThe hepatoprotective activity of UA against chronic alcohol-induced liver injury was investigated on Lieber-DeCarli liquid diet-based mouse model. In-depth RNA-seq transcriptomics and TMT-based proteomics analyses were conducted in parallel. Data integration as well as bioinformatics analysis were also performed to unravel the targets and mechanisms associated with the hepatoprotective activity of UA intake against alcoholic liver injury comprehensively.

resultsThe serum biomarkers and pathological characteristics indicated the hepatoprotective effects of UA intake on alcoholic liver injury. 567 target genes and 377 target proteins related to the hepatoprotective activity of UA were identified in transcriptomics and proteomics analysis respectively, most of which were associated with function of cellular process, cell part and binding. After data integration, 56 co-regulated targets, including ADH4, CYP450 enzymes, NQO1, apolipoproteins, glutathione-S-transferase, etc. which were consistently modulated on both mRNA and protein levels were identified. These co-regulated targets were found to be correlated with 70 KEGG pathways led by carcinogenesis, retinol metabolism and CYP450 metabolism pathways.

conclusionUA intake ameliorated chronic alcohol-induced liver injury. Given the role of the co-regulated targets in ALD and the bioinformatics analysis results, CYP450-, glutathione and redox homeostasis-dependent antioxidation, promotion of lipid transport, and restoration of ethanol metabolic capacity are the potentially underlying mechanisms. This information will further deepen our insights into the hepatoprotective effects of UA-rich edible plants, and provide us valuable instruction for ALD management.

Indexed as

AlcoholismLiver Diseases, AlcoholicTriterpenesAlcohol DrinkingAnimalsLiverMiceUrsolic AcidTriterpenesUrsolic AcidAlcoholic liver injuryHepatoprotective activityMolecular mechanismMulti-omics integrationUrsolic acid

Identifiers

PMID34215920
OpenAlexW3176744425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.